Oncology Therapeutics · Health Care
Inspirna: Products & infrastructure
Inspirna has 3 clinical trials on record, 0 under way.
Data updated Nov 20, 2026 · Back to the company report
Products
Inspirna has 3 clinical trials on record, 0 under way.
3clinical trials
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
phase 2 · stopped or withdrawn · 76 participants · Colorectal Cancer; Metastatic Colon Cancer
Oct 2023
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
phase 1 · completed · 89 participants · Gastrointestinal Cancer; Gastrointestinal Neoplasms; Colorectal Cancer; Colorec…
Jun 2018
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
phase 1 · completed · 146 participants · Endometrial Cancer; Endometrial Cancer Recurrent; Lung Cancer Recurrent; Lung C…
Nov 2016
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
